Copyright Reports & Markets. All rights reserved.

Global Protein Drugs Market Size, Status and Forecast 2020-2026

Request for Sample of this report
Buy now

1 Report Overview

  • 1.1 Study Scope
  • 1.2 Key Market Segments
  • 1.3 Players Covered: Ranking by Protein Drugs Revenue
  • 1.4 Market by Type
    • 1.4.1 Global Protein Drugs Market Size Growth Rate by Type: 2020 VS 2026
    • 1.4.2 Antibody Drugs
    • 1.4.3 Peptide Hormones
    • 1.4.4 Blood Products
    • 1.4.5 Enzymes
  • 1.5 Market by Application
    • 1.5.1 Global Protein Drugs Market Share by Application: 2020 VS 2026
    • 1.5.2 Hospitals
    • 1.5.3 Clinics
    • 1.5.4 Other
  • 1.6 Study Objectives
  • 1.7 Years Considered

2 Global Growth Trends

  • 2.1 Global Protein Drugs Market Perspective (2015-2026)
  • 2.2 Global Protein Drugs Growth Trends by Regions
    • 2.2.1 Protein Drugs Market Size by Regions: 2015 VS 2020 VS 2026
    • 2.2.2 Protein Drugs Historic Market Share by Regions (2015-2020)
    • 2.2.3 Protein Drugs Forecasted Market Size by Regions (2021-2026)
  • 2.3 Industry Trends and Growth Strategy
    • 2.3.1 Market Top Trends
    • 2.3.2 Market Drivers
    • 2.3.3 Market Challenges
    • 2.3.4 Porter’s Five Forces Analysis
    • 2.3.5 Protein Drugs Market Growth Strategy
    • 2.3.6 Primary Interviews with Key Protein Drugs Players (Opinion Leaders)

3 Competition Landscape by Key Players

  • 3.1 Global Top Protein Drugs Players by Market Size
    • 3.1.1 Global Top Protein Drugs Players by Revenue (2015-2020)
    • 3.1.2 Global Protein Drugs Revenue Market Share by Players (2015-2020)
    • 3.1.3 Global Protein Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.2 Global Protein Drugs Market Concentration Ratio
    • 3.2.1 Global Protein Drugs Market Concentration Ratio (CR5 and HHI)
    • 3.2.2 Global Top 10 and Top 5 Companies by Protein Drugs Revenue in 2019
  • 3.3 Protein Drugs Key Players Head office and Area Served
  • 3.4 Key Players Protein Drugs Product Solution and Service
  • 3.5 Date of Enter into Protein Drugs Market
  • 3.6 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)

  • 4.1 Global Protein Drugs Historic Market Size by Type (2015-2020)
  • 4.2 Global Protein Drugs Forecasted Market Size by Type (2021-2026)

5 Market Size by Application (2015-2026)

  • 5.1 Global Protein Drugs Market Size by Application (2015-2020)
  • 5.2 Global Protein Drugs Forecasted Market Size by Application (2021-2026)

6 North America

  • 6.1 North America Protein Drugs Market Size (2015-2020)
  • 6.2 Protein Drugs Key Players in North America (2019-2020)
  • 6.3 North America Protein Drugs Market Size by Type (2015-2020)
  • 6.4 North America Protein Drugs Market Size by Application (2015-2020)

7 Europe

  • 7.1 Europe Protein Drugs Market Size (2015-2020)
  • 7.2 Protein Drugs Key Players in Europe (2019-2020)
  • 7.3 Europe Protein Drugs Market Size by Type (2015-2020)
  • 7.4 Europe Protein Drugs Market Size by Application (2015-2020)

8 China

  • 8.1 China Protein Drugs Market Size (2015-2020)
  • 8.2 Protein Drugs Key Players in China (2019-2020)
  • 8.3 China Protein Drugs Market Size by Type (2015-2020)
  • 8.4 China Protein Drugs Market Size by Application (2015-2020)

9 Japan

  • 9.1 Japan Protein Drugs Market Size (2015-2020)
  • 9.2 Protein Drugs Key Players in Japan (2019-2020)
  • 9.3 Japan Protein Drugs Market Size by Type (2015-2020)
  • 9.4 Japan Protein Drugs Market Size by Application (2015-2020)

10 Southeast Asia

  • 10.1 Southeast Asia Protein Drugs Market Size (2015-2020)
  • 10.2 Protein Drugs Key Players in Southeast Asia (2019-2020)
  • 10.3 Southeast Asia Protein Drugs Market Size by Type (2015-2020)
  • 10.4 Southeast Asia Protein Drugs Market Size by Application (2015-2020)

11 India

  • 11.1 India Protein Drugs Market Size (2015-2020)
  • 11.2 Protein Drugs Key Players in India (2019-2020)
  • 11.3 India Protein Drugs Market Size by Type (2015-2020)
  • 11.4 India Protein Drugs Market Size by Application (2015-2020)

12 Central & South America

  • 12.1 Central & South America Protein Drugs Market Size (2015-2020)
  • 12.2 Protein Drugs Key Players in Central & South America (2019-2020)
  • 12.3 Central & South America Protein Drugs Market Size by Type (2015-2020)
  • 12.4 Central & South America Protein Drugs Market Size by Application (2015-2020)

13 Key Players Profiles

  • 13.1 Eli Lilly
    • 13.1.1 Eli Lilly Company Details
    • 13.1.2 Eli Lilly Business Overview
    • 13.1.3 Eli Lilly Protein Drugs Introduction
    • 13.1.4 Eli Lilly Revenue in Protein Drugs Business (2015-2020))
    • 13.1.5 Eli Lilly Recent Development
  • 13.2 Abbott Laboratories
    • 13.2.1 Abbott Laboratories Company Details
    • 13.2.2 Abbott Laboratories Business Overview
    • 13.2.3 Abbott Laboratories Protein Drugs Introduction
    • 13.2.4 Abbott Laboratories Revenue in Protein Drugs Business (2015-2020)
    • 13.2.5 Abbott Laboratories Recent Development
  • 13.3 UCB Group
    • 13.3.1 UCB Group Company Details
    • 13.3.2 UCB Group Business Overview
    • 13.3.3 UCB Group Protein Drugs Introduction
    • 13.3.4 UCB Group Revenue in Protein Drugs Business (2015-2020)
    • 13.3.5 UCB Group Recent Development
  • 13.4 Schering-Plough Corporation
    • 13.4.1 Schering-Plough Corporation Company Details
    • 13.4.2 Schering-Plough Corporation Business Overview
    • 13.4.3 Schering-Plough Corporation Protein Drugs Introduction
    • 13.4.4 Schering-Plough Corporation Revenue in Protein Drugs Business (2015-2020)
    • 13.4.5 Schering-Plough Corporation Recent Development
  • 13.5 Genentech
    • 13.5.1 Genentech Company Details
    • 13.5.2 Genentech Business Overview
    • 13.5.3 Genentech Protein Drugs Introduction
    • 13.5.4 Genentech Revenue in Protein Drugs Business (2015-2020)
    • 13.5.5 Genentech Recent Development
  • 13.6 Johnson＆Johnson
    • 13.6.1 Johnson＆Johnson Company Details
    • 13.6.2 Johnson＆Johnson Business Overview
    • 13.6.3 Johnson＆Johnson Protein Drugs Introduction
    • 13.6.4 Johnson＆Johnson Revenue in Protein Drugs Business (2015-2020)
    • 13.6.5 Johnson＆Johnson Recent Development
  • 13.7 Bristol-Myers Squibb
    • 13.7.1 Bristol-Myers Squibb Company Details
    • 13.7.2 Bristol-Myers Squibb Business Overview
    • 13.7.3 Bristol-Myers Squibb Protein Drugs Introduction
    • 13.7.4 Bristol-Myers Squibb Revenue in Protein Drugs Business (2015-2020)
    • 13.7.5 Bristol-Myers Squibb Recent Development
  • 13.8 Novo Nordisk
    • 13.8.1 Novo Nordisk Company Details
    • 13.8.2 Novo Nordisk Business Overview
    • 13.8.3 Novo Nordisk Protein Drugs Introduction
    • 13.8.4 Novo Nordisk Revenue in Protein Drugs Business (2015-2020)
    • 13.8.5 Novo Nordisk Recent Development
  • 13.9 Biogen Idec
    • 13.9.1 Biogen Idec Company Details
    • 13.9.2 Biogen Idec Business Overview
    • 13.9.3 Biogen Idec Protein Drugs Introduction
    • 13.9.4 Biogen Idec Revenue in Protein Drugs Business (2015-2020)
    • 13.9.5 Biogen Idec Recent Development
  • 13.10 Dendreon Corporation
    • 13.10.1 Dendreon Corporation Company Details
    • 13.10.2 Dendreon Corporation Business Overview
    • 13.10.3 Dendreon Corporation Protein Drugs Introduction
    • 13.10.4 Dendreon Corporation Revenue in Protein Drugs Business (2015-2020)
    • 13.10.5 Dendreon Corporation Recent Development
  • 13.11 Amgen Inc.
    • 10.11.1 Amgen Inc. Company Details
    • 10.11.2 Amgen Inc. Business Overview
    • 10.11.3 Amgen Inc. Protein Drugs Introduction
    • 10.11.4 Amgen Inc. Revenue in Protein Drugs Business (2015-2020)
    • 10.11.5 Amgen Inc. Recent Development

14 Analyst's Viewpoints/Conclusions

    15 Appendix

    • 15.1 Research Methodology
      • 15.1.1 Methodology/Research Approach
      • 15.1.2 Data Source
    • 15.2 Disclaimer

    Protein Drugs market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Protein Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

    The key players covered in this study
    Eli Lilly
    Abbott Laboratories
    UCB Group
    Schering-Plough Corporation
    Genentech
    Johnson＆Johnson
    Bristol-Myers Squibb
    Novo Nordisk
    Biogen Idec
    Dendreon Corporation
    Amgen Inc.

    Market segment by Type, the product can be split into
    Antibody Drugs
    Peptide Hormones
    Blood Products
    Enzymes
    Market segment by Application, split into
    Hospitals
    Clinics
    Other

    Market segment by Regions/Countries, this report covers
    North America
    Europe
    China
    Japan
    Southeast Asia
    India
    Central & South America

    Buy now